Literature DB >> 909110

Murine colon adenocarcinoma: syngeneic orthotopic transplantation and subsequent hepatic metastases.

M H Tan, E D Holyoke, M H Goldrosen.   

Abstract

Syngeneic murine colon adenocarcinoma (MCA-38) cells were transplanted in the submucosa of distal colon, proximal colon, cecum, ileum, jejunum, and duodenum of male C57BL/6 mice, with local lymphoid follicles used as points of entry. The tumor grew best at the cecum and led to liver and mesenteric lymph node metastases in 8 and 9 weeks, respectively, after transplantation. Histologically, a local inflammatory reaction involving polymorphonuclear leukocytes was observed within 48-72 hours following transplantation; after this time, the microscopic tumor foci began to grow progressively. Mononuclear lymphoid cells of the gut-associated lymphoid tissue did not infiltrate the progressively growing tumor; however, polymorphonuclear leukocytes were constantly observed at the tumor periphery in the lamina propria. The studies indicated that orthotopic transplantation as a model system can provide a means of examining the role of the local immune response as a focus of host resistance and as a factor in metastatic tumor spread. The findings also suggested the usefulness of this model in immunotherapeutic and chemotherapeutic studies of secondary hepatic disease.

Entities:  

Mesh:

Year:  1977        PMID: 909110     DOI: 10.1093/jnci/59.5.1537

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  15 in total

1.  Hydrodynamic cell delivery for simultaneous establishment of tumor growth in mouse lung, liver and kidney.

Authors:  Jianfeng Li; Qian Yao; Dexi Liu
Journal:  Cancer Biol Ther       Date:  2011-10-15       Impact factor: 4.742

2.  Rodent models for carcinoma of the colon.

Authors:  A E Rogers; K M Nauss
Journal:  Dig Dis Sci       Date:  1985-12       Impact factor: 3.199

Review 3.  Cellular interactions in metastasis.

Authors:  F R Miller; G H Heppner
Journal:  Cancer Metastasis Rev       Date:  1990-07       Impact factor: 9.264

4.  Hypoxia in models of lung cancer: implications for targeted therapeutics.

Authors:  Edward E Graves; Marta Vilalta; Ivana K Cecic; Janine T Erler; Phuoc T Tran; Dean Felsher; Leanne Sayles; Alejandro Sweet-Cordero; Quynh-Thu Le; Amato J Giaccia
Journal:  Clin Cancer Res       Date:  2010-09-21       Impact factor: 12.531

5.  An orthotopic colon cancer model for studying the B7-H3 antitumor effect in vivo.

Authors:  Catalin M Lupu; Christoph Eisenbach; Michael A Kuefner; Jan Schmidt; Alaviana D Lupu; Wolfgang Stremmel; Jens Encke
Journal:  J Gastrointest Surg       Date:  2006-05       Impact factor: 3.452

Review 6.  Murine models to evaluate novel and conventional therapeutic strategies for cancer.

Authors:  James E Talmadge; Rakesh K Singh; Isaiah J Fidler; Avraham Raz
Journal:  Am J Pathol       Date:  2007-03       Impact factor: 4.307

7.  Adjuvant chemotherapy in a new metastasizing caecum tumor model.

Authors:  F A Zoetmulder; A Zwaveling
Journal:  Clin Exp Metastasis       Date:  1983 Oct-Dec       Impact factor: 5.150

8.  Growth and metastasis of human breast cancers in athymic nude mice.

Authors:  M S Murthy; E F Scanlon; M L Jelachich; S Klipstein; R A Goldschmidt
Journal:  Clin Exp Metastasis       Date:  1995-01       Impact factor: 5.150

9.  Reverse-Contrast Imaging and Targeted Radiation Therapy of Advanced Pancreatic Cancer Models.

Authors:  Daniel L J Thorek; Robin M Kramer; Qing Chen; Jeho Jeong; Mihaela E Lupu; Alycia M Lee; Mary E Moynahan; Maeve Lowery; David Ulmert; Pat Zanzonico; Joseph O Deasy; John L Humm; James Russell
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-06-09       Impact factor: 7.038

Review 10.  Xenograft models of head and neck cancers.

Authors:  Daisuke Sano; Jeffrey N Myers
Journal:  Head Neck Oncol       Date:  2009-08-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.